thumbnail image
Allegrow Biotech Logo
Allegrow Biotech Logo
  • Products 
    • AimGel
    • Cells
  • Technology 
    • Overview
    • Deep Dive
  • About 
    • Our Team
    • Our Story
    • News
    • Contact
  • Resources 
    • Product Resources
    • Investor Teaser
    • AimGel Builder
  • …  
    • Products 
      • AimGel
      • Cells
    • Technology 
      • Overview
      • Deep Dive
    • About 
      • Our Team
      • Our Story
      • News
      • Contact
    • Resources 
      • Product Resources
      • Investor Teaser
      • AimGel Builder
    Where to Buy
    Allegrow Biotech Logo
    Allegrow Biotech Logo
    • Products 
      • AimGel
      • Cells
    • Technology 
      • Overview
      • Deep Dive
    • About 
      • Our Team
      • Our Story
      • News
      • Contact
    • Resources 
      • Product Resources
      • Investor Teaser
      • AimGel Builder
    • …  
      • Products 
        • AimGel
        • Cells
      • Technology 
        • Overview
        • Deep Dive
      • About 
        • Our Team
        • Our Story
        • News
        • Contact
      • Resources 
        • Product Resources
        • Investor Teaser
        • AimGel Builder
      Where to Buy
      Allegrow Biotech Logo
      • AimGel Human T Cell Activator

        CD3/CD28/CD137 activation on cell-sized hydrogel microparticles

        AimGel Human T Cell Activator

        AimGel Human T Cell Activator

        $150.00
        ATC01-0050H | Research Use Only

        AimGel Human T Cell Activator presents anti-CD3, anti-CD28 and anti-CD137 signals on soft hydrogel microparticles built to the size of a real cell (10-15 µm). The fluid lipid membrane lets those signals move freely across the surface, the way they do on a natural antigen-presenting cell — so activation is gentle and effective, whether you start from isolated T cells or straight from PBMC.

        1 vial of AimGel Human T Cell Activator, 0.5 mL in PBS at 4 × 10⁷ microparticles/mL
        Quantity
        Coming soon
      • Performance

        Quantity and quality

        AimGel yields 60% more T cells than existing synthetic solutions such as magnetic beads and nanomatrix, in less time, with matching viability (n=4, PBMCs from healthy human donors). Because the signals are presented gently rather than forced, cells come through with less exhaustion, they stay responsive, and you can re-stimulate.

        Built to mimic an antigen-presenting cell

        The soft hydrogel core matches the mechanical stiffness and size of a real cell, while a mobile lipid bilayer lets activation signals travel across the surface just as they would on a natural APC. That biomimicry is why AimGel needs significantly fewer activation signals than rigid magnetic beads while activating more effectively, and also more gently.

        Self-degradable via hydrolysis

        As hydrogel microparticles, AimGel self-degrades via hydrolysis. So say goodbye to pesky debeading steps and hello to a streamlined workflow. Need them gone sooner? The included lysis buffer clears them on demand.

      • Product Details

        Specifications

        A suspension of AimGel hydrogel microparticles made of chemically crosslinked dextran. Microparticles sized ~10-15 µm, coated with a phospholipid bilayer, with human T cell activating signal panels docked to the membrane.

        Inside the kit

        • 1 vial of AimGel Human T Cell Activator in PBS at 4 × 10⁷ microparticles/mL, with 0.5% P/S
        • 1 vial of lysis buffer (100×), dextranase in PBS

        Storage & stability

        • Ships on ice
        • Do not freeze, keep refrigerated at 2–8 °C, stable for 12 months.
        • Contents are sterile when unopened

        You will also need

        • Cryopreserved or freshly isolated T cells, or CD3⁺ T cells
        • RPMI 1640 supplemented with 2 mM L-glutamine, or equivalent
        • Heat-inactivated fetal bovine serum (FBS)
        • Penicillin/streptomycin
        • Recombinant human IL-2 (rIL-2)
        • 2-Mercaptoethanol
        • Cell culture vessels
        • Humidified CO₂ incubator or bioreactor

        Documents

        • Datasheet
        • Protocol
      • Data

        Section image

        Proliferation and viability

        AimGel outperforms existing synthetic solutions such as magnetic beads and nanomatrix by 60%, yielding more T cells in a shorter time. Viability of T cells activated via AimGel matches current synthetic solutions. n=4, PBMCs from healthy human donors.

        Section image

        Memory subtypes

        T cell memory subtypes of PBMCs activated by AimGel and other popular T cell activation reagents. AimGel produces more even fractions of effector memory and central memory subtypes.

        Section image

        Activation markers

        Expression of early-stage marker (CD69) and late-stage marker (CD25), indicating T cell activation. Unstimulated cells used as gating.

        Section image

        CAR-T function

        In vitro CAR-T cell mediated killing assessed by fluorescent microscopy of GFP⁺ Raji cancer cell lines co-cultured with CAR-T cells.

        Section image

        Degradation timecourse

        Bright-field micrographs showing activation and expansion of pan T cells at days 2, 3, 5 and 7. Scale bar = 50 µm. T cells activated and expanded using AimGel at a 1:1 microparticle-to-cell ratio. Red signals indicate the AimGel microparticles. T cell AimGel clusters are visible on day 2 and enlarged by day 3. Red signals disappear as the microparticles begin degrading and dissociate from T cells on day 5. By day 7 the microparticles are degraded, releasing the T cells.

      • AimGel FAQs

        What are the major advantages of using the AimGel Human T Cell Activator to expand T cells?

        Here are the major advantages of using AimGel for human T cell activation:
        1. Higher expansion: AimGel show higher T cell activation compared to aCD3/aCD28 microplastic beads.
        2. More and longer-lasting memory cells: T-cells enriched with AimGel show a higher central memory and effector memory T cell subsets compared to aCD3/aCD28 microplastic beads.
        3. Less exhaustion: T-cells enriched with AimGel show less exhaustion compared to aCD3/aCD28 microplastic beads
        4. Natural-like cell-cell interaction: Fluid lipid membrane enabling near-native cell-to-cell interaction.
        5. No de-beading step: Degradable AimGel microparticles negates the need for de-beading steps.

        When activating or expanding T cells using AimGel, how many cells do I have to seed to start the culture?

        Recommended parameters:
        • Cell seeding density: 2×10⁵ - 3×10⁵ cell per cm²
        • AimGel microparticle to PBMC ratio 3:1
        • AimGel microparticle to T cell ratio 2:1

        How to remove the AimGel microparticles?

        AimGel microparticles self-degrade by hydrolysis after around 14 days in culture. If you need them gone sooner, the included lysis buffer degrades them enzymatically into non-toxic polymeric components. See the protocol for timings.

        What should I do if I see cell clustering during cell culture?

        Cells and AimGel microparticles tend to aggregate in the well center over time. Gently shake the culture plate to redistribute AimGel microparticles and cells. Avoid unnecessary pipette mixing in the first 5 days, disturbing the AimGel-cell clustering will cause suboptimal cell growth.

        Can I re-stimulate my T cells with AimGel?

        For expansion longer than 10 days, restimulation is required and possible. Cell growth usually slows down after day 10 after initial activation. Recommended AimGel microparticle to cell ratio for restimulation is 0.5:1 to 1:1, perform 9-11 days after previous stimulation.
      • Order Now

        Purchase through our distributors, or our webstore if no distributor is serving your region.

        LAB-A-PORTER logo, distributor for Hong Kong

        LAB-A-PORTER

        Hong Kong

        Buy on LAB-A-PORTER

        Allegrow Webstore

        Other regions

        Allegrow Webstore
      Powered By
        Cookie Use
        We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
        Learn More